|
Volumn 54, Issue 3, 2001, Pages 301-305
|
T-cell mean telomere lengths changes in treatment naïve HIV-infected patients randomized to G-CSF or placebo simultaneously with initiation of HAART
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
GRANULOCYTE COLONY STIMULATING FACTOR;
INDINAVIR;
LAMIVUDINE;
NELFINAVIR;
NEVIRAPINE;
RITONAVIR;
STAVUDINE;
VIRUS RNA;
ZIDOVUDINE;
ADULT;
ARTICLE;
CELL ISOLATION;
CHROMOSOME SIZE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
FOLLOW UP;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN CELL;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LYMPHOCYTE COUNT;
MALE;
MONONUCLEAR CELL;
NEUTROPENIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RESTRICTION FRAGMENT;
T LYMPHOCYTE;
TELOMERE;
VIRUS LOAD;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4-POSITIVE T-LYMPHOCYTES;
CD8-POSITIVE T-LYMPHOCYTES;
DRUG THERAPY, COMBINATION;
FEMALE;
GRANULOCYTE COLONY-STIMULATING FACTOR;
HIV INFECTIONS;
HUMANS;
MALE;
TELOMERE;
|
EID: 0035720327
PISSN: 03009475
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-3083.2001.00935.x Document Type: Article |
Times cited : (7)
|
References (18)
|